We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

NNDM:NASDAQNano Dimension Ltd. Analysis

Data as of 2026-04-20 - not real-time

$1.77

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

Technical outlook: The 20‑day SMA sits below the 50‑day SMA, suggesting short‑term pressure, while the 200‑day SMA remains lower, keeping the broader trend neutral. RSI hovers just above the 50 mark, indicating no clear overbought or oversold condition. A bullish MACD histogram coupled with a bullish signal line hints at a potential near‑term upside despite the neutral trend direction.
Fundamentals & news: Revenue surged dramatically year‑over‑year, yet earnings remain deeply negative, reflected in an astronomically high forward PE relative to the industry average. The company’s cash position is strong, and recent strategic moves—including the sale of its additively manufactured electronics and Fabrica lines—are projected to cut annualized cash burn by $10 million, improving runway. However, volume is decreasing, beta is elevated, and 30‑day volatility approaches 50 %, underscoring heightened market risk.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 5/10

Key Factors

  • Bullish MACD signal amid neutral SMA alignment
  • Decreasing trading volume raising liquidity concerns
  • Recent asset divestitures creating short‑term uncertainty

Medium Term

1–3 years
Neutral
Model confidence: 6/10

Key Factors

  • Projected $10 M reduction in cash burn improving financial runway
  • Strong cash balance offsetting high debt‑to‑equity ratio
  • Revenue growth driven by recent acquisitions but profitability remains elusive

Long Term

> 3 years
Neutral
Model confidence: 5/10

Key Factors

  • Potential strategic pivot after sale of core 3D‑printed electronics business
  • Elevated beta and volatility indicating sensitivity to market swings
  • Absence of dividend and ongoing negative earnings limiting upside

Key Metrics & Analysis

Financial Health

Revenue Growth113.50%
Profit Margin-286.32%
P/E Ratio177.0
ROE-14.21%
ROA-6.19%
Debt/Equity5.90
P/B Ratio0.6
Op. Cash Flow$-101284000
Free Cash Flow$-43309376
Industry P/E36.7

Technical Analysis

TrendNeutral
RSI52.8
Support$1.55
Resistance$1.85
MA 20$1.71
MA 50$1.82
MA 200$1.66
MACDBullish
VolumeDecreasing
Fear & Greed Index87.21

Valuation

GradeOvervalued
TypeBlend

Risk Assessment

Beta1.70
Volatility48.91%
Sector RiskMedium
Reg. RiskLow
Geo RiskLow
Currency RiskLow
Liquidity RiskHigh

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.